IL-6 in inflammation, autoimmunity and cancer.
IL-6 in inflammation, autoimmunity and cancer.
复制标题
白细胞介素 - 6在炎症、自身免疫和癌症中的作用(此处如果单纯翻译原句是“白细胞介素 - 6在炎症、自身免疫和癌症中”,但感觉原句可能是关于白细胞介素 - 6在这些方面的相关研究或作用等主题的一部分,所以补充“的作用”使译文更通顺合理)
DOI:
10.1093/intimm/dxaa078
复制
发表时间:
2021-03-01
影响因子:
4.4
通讯作者:
Hirano T
中科院分区:
文献类型:
--
作者:
Hirano T
IL-6: a nexus for immune responses and disease IL-6 is involved both in immune responses and in inflammation, hematopoiesis, bone metabolism and embryonic development. IL-6 plays roles in chronic inflammation (closely related to chronic inflammatory diseases, autoimmune diseases and cancer) and even in the cytokine storm of corona virus disease 2019 (COVID-19). Acute inflammation during the immune response and wound healing is a well-controlled response, whereas chronic inflammation and the cytokine storm are uncontrolled inflammatory responses. Non-immune and immune cells, cytokines such as IL-1β, IL-6 and tumor necrosis factor alpha (TNFα) and transcription factors nuclear factor-kappa B (NF-κB) and signal transducer and activator of transcription 3 (STAT3) play central roles in inflammation. Synergistic interactions between NF-κB and STAT3 induce the hyper-activation of NF-κB followed by the production of various inflammatory cytokines. Because IL-6 is an NF-κB target, simultaneous activation of NF-κB and STAT3 in non-immune cells triggers a positive feedback loop of NF-κB activation by the IL-6–STAT3 axis. This positive feedback loop is called the IL-6 amplifier (IL-6 Amp) and is a key player in the local initiation model, which states that local initiators, such as senescence, obesity, stressors, infection, injury and smoking, trigger diseases by promoting interactions between non-immune cells and immune cells. This model counters dogma that holds that autoimmunity and oncogenesis are triggered by the breakdown of tissue-specific immune tolerance and oncogenic mutations, respectively. The IL-6 Amp is activated by a variety of local initiators, demonstrating that the IL-6–STAT3 axis is a critical target for treating diseases.
登录
查看更多内容
影响因子:
30.5
作者:
Acosta-Rodriguez, Eva V.;Napolitani, Giorgio;Sallusto, Federica
通讯作者:
Sallusto, Federica
影响因子:
64.8
作者:
Bettelli, E;Carrier, YJ;Kuchroo, VK
通讯作者:
Kuchroo, VK
影响因子:
11.4
作者:
AKIRA, S;ISSHIKI, H;KISHIMOTO, T
通讯作者:
KISHIMOTO, T
影响因子:
20.3
作者:
BATAILLE, R;BARLOGIE, B;KLEIN, B
通讯作者:
KLEIN, B
影响因子:
3.7
作者:
Anand, Preetha;Kunnumakara, Ajaikumar B.;Sundaram, Chitra;Harikumar, Kuzhuvelil B.;Tharakan, Sheeja T.;Lai, Oiki S.;Sung, Bokyung;Aggarwal, Bharat B.
通讯作者:
Aggarwal, Bharat B.